These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19788631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
    Albayrak Y, Ünsal C, Beyazyüz M, Ünal A, Kuloğlu M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():144-9. PubMed ID: 23657077
    [Abstract] [Full Text] [Related]

  • 3. A defect in the antioxidant defense system in schizophrenia.
    Virit O, Altindag A, Yumru M, Dalkilic A, Savas HA, Selek S, Erel O, Herken H.
    Neuropsychobiology; 2009 Aug 01; 60(2):87-93. PubMed ID: 19776652
    [Abstract] [Full Text] [Related]

  • 4. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC, Yon V, Loas G, Noisette C.
    Encephale; 2000 Aug 01; 26(6):32-41. PubMed ID: 11217537
    [Abstract] [Full Text] [Related]

  • 5. Testosterone in first-episode schizophrenia.
    Cesková E, Prikryl R, Kaspárek T.
    Neuro Endocrinol Lett; 2007 Dec 01; 28(6):811-4. PubMed ID: 18063925
    [Abstract] [Full Text] [Related]

  • 6. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
    Moukas G, Stathopoulou A, Gourzis P, Beratis IN, Beratis S.
    Compr Psychiatry; 2010 Dec 01; 51(1):1-7. PubMed ID: 19932819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Schizophrenia and hospitalization.
    Ali W.
    J Coll Physicians Surg Pak; 2006 Mar 01; 16(3):223-6. PubMed ID: 16542606
    [Abstract] [Full Text] [Related]

  • 9. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A.
    Eur Neuropsychopharmacol; 2004 Aug 01; 14(4):267-73. PubMed ID: 15163435
    [Abstract] [Full Text] [Related]

  • 10. Total antioxidant response in patients with schizophrenia.
    Ustundag B, Atmaca M, Kirtas O, Selek S, Metin K, Tezcan E.
    Psychiatry Clin Neurosci; 2006 Aug 01; 60(4):458-64. PubMed ID: 16884448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relationship between leptin level and oxidative status parameters in hemodialysis patients.
    Horoz M, Aslan M, Koylu AO, Bolukbas C, Bolukbas FF, Selek S, Erel O.
    Artif Organs; 2009 Jan 01; 33(1):81-5. PubMed ID: 19178446
    [Abstract] [Full Text] [Related]

  • 13. Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up study.
    Ritsner MS, Ratner Y, Gibel A, Weizman R.
    Psychiatry Res; 2007 Dec 03; 153(3):217-23. PubMed ID: 17675246
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
    Hons J, Zirko R, Ulrychova M, Cermakova E, Libiger J.
    Neuro Endocrinol Lett; 2008 Aug 03; 29(4):485-92. PubMed ID: 18766161
    [Abstract] [Full Text] [Related]

  • 17. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings.
    Walther S, Koschorke P, Horn H, Strik W.
    Psychiatry Res; 2009 Oct 30; 169(3):187-90. PubMed ID: 19729205
    [Abstract] [Full Text] [Related]

  • 18. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1095-100. PubMed ID: 17493732
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W.
    J Psychiatr Pract; 2008 Mar 30; 14(2):105-13. PubMed ID: 18360196
    [Abstract] [Full Text] [Related]

  • 20. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G, Azi A, Noisette C, Yon V.
    Encephale; 2008 Jan 30; 34(1):54-60. PubMed ID: 18514151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.